Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors

Leuk Lymphoma. 2017 Mar;58(3):726-728. doi: 10.1080/10428194.2016.1211276. Epub 2016 Aug 9.

Authors

Katerina Gemenetzi¹, Chrysi Galigalidou¹, Elisavet Vlachonikola¹, Evangelia Stalika^{1

2}, Aliki Xochelli^{1

2}, Panagiotis Baliakas³, Maria Karypidou², Tasoula Touloumenidou², Evangelia Minga¹, Vasiliki Douka², Michalis Iskas², Anastasia Athanasiadou², Antonios Makris¹, Niki Stavroyianni², Achilles Anagnostopoulos², Anastasia Hadzidimitriou^{1

3}, Kostas Stamatopoulos^{1

3}

Affiliations

¹ a Institute of Applied Biosciences, Center of Research and Technology Hellas , Thessaloniki , Greece.
² b Hematology Department and HCT Unit , G. Papanicolaou Hospital , Thessaloniki , Greece.
³ c Department of Immunology, Genetics and Pathology, Science for Life Laboratory , Uppsala University , Uppsala , Sweden.

PMID: 27686405
DOI: 10.1080/10428194.2016.1211276

No abstract available

Publication types

Letter

MeSH terms

Alleles*
Amino Acid Substitution
Codon
Gene Rearrangement
Genes, p53*
Humans
Immunoglobulin Heavy Chains / genetics
Immunoglobulin Variable Region / genetics
Incidence
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Mutation
Phenotype
Polymorphism, Single Nucleotide*

Substances

Codon
Immunoglobulin Heavy Chains
Immunoglobulin Variable Region